Answer

Psilocybin remains a controlled substance under the Controlled Drugs and Substances Act. However, Health Canada may grant exemptions under Section 56 or authorize use through the Special Access Program (SAP) for individuals with serious or life-threatening conditions when other treatments have failed. A small number of clinical trials and compassionate-use exemptions have been approved in Canada.